Prevention of ovariectomy-induced changes in the Sprague-Dawley rat by the selective estrogen receptor modulator HMR 3339.

被引：0
|
作者：
Smith, SY
Jolette, J
Leyshon, AM
Turner, CH
Gaillard-Kelly, M
Vidal, JM
Baron, R
机构：
[1] Proskelia, Romainville, France
[2] Aventis Pharma, Romainville, France
[3] Indiana Univ, Indianapolis, IN 46204 USA
[4] CTBR, Montreal, PQ, Canada
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
M379
引用
收藏
页码：S480 / S480
页数：1
相关论文
共 48 条
  • [31] Proliferative lesions of ovarian granulosa cells and reversible hormonal changes induced in rats by a selective estrogen receptor modulator
    Long, GG
    Cohen, IR
    Gries, CL
    Young, JK
    Francis, PC
    Capen, CC
    TOXICOLOGIC PATHOLOGY, 2001, 29 (04) : 403 - 410
  • [32] The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: A randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women
    Vogelvang, TE
    Mijatovic, V
    Kenemans, P
    Emeis, JJ
    Heijst, JA
    van der Mooren, MJ
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (04) : 1384 - 1394
  • [33] Effects on asymmetric dimethylarginine of HMR 3339, a novel selective estrogen receptor modulator: a 12-week, randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women
    Verhoeven, Marieke O.
    Teerlink, Tom
    Kenemans, Peter
    Vogelvang, Tatjana E.
    van der Mooren, Marius J.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (02): : 235 - 242
  • [34] Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats
    Rezvani, Amir H.
    Cauley, Marty
    Sexton, Hannah
    Xiao, Yingxian
    Brown, Milton L.
    Paige, Mikell A.
    McDowell, Brian E.
    Kellar, Kenneth J.
    Levin, Edward D.
    PSYCHOPHARMACOLOGY, 2011, 215 (04) : 621 - 630
  • [35] Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model
    Lee, Young-Seok
    Gupta, Rishab
    Kwon, Jeong-Taik
    Cho, Dae-Chul
    Seo, Ye Jin
    Seu, Sung Young
    Park, Eui Kyun
    Han, Inbo
    Kim, Chi-Heon
    Sung, Joo-Kyung
    Kim, Kyoung-Tae
    SPINE JOURNAL, 2018, 18 (10): : 1877 - 1887
  • [36] SELECTIVE ESTROGEN RECEPTOR MODULATOR CAN IMPROVE BENIGN PROSTATIC HYPERPLASIA IN HIGH FAT INDUCED OBESITY RAT MODEL
    Yamanaka, Naoyuki
    Mori, Kenichi
    Mizoguchi, Shinsuke
    Shin, Toshitaka
    Mimata, Hiromitsu
    JOURNAL OF UROLOGY, 2019, 201 (04): : E48 - E48
  • [37] Differences in kinetics of induction and reversibility of TCDD-induced changes in cell proliferation and CYP1A1 expression in female Sprague-Dawley rat liver
    Walker, NJ
    Miller, BD
    Kohn, MC
    Lucier, GW
    Tritscher, AM
    CARCINOGENESIS, 1998, 19 (08) : 1427 - 1435
  • [38] The new selective estrogen receptor modulator MDL 103,323 reverses the decrease in bone mass and bone fragility induced by ovariectomy in adult rats.
    Ammann, P
    Rizzoli, R
    Meyer, JM
    Brunner, F
    Bonjour, JP
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S434 - S434
  • [39] Therapeutic effect of protease-activated receptor 2 agonist SLIGRL-NH2 on loperamide-induced Sprague-Dawley rat constipation model and the related mechanism
    Zhang, Yonggang
    Ge, Tingrui
    Xiang, Ping
    Mao, Haibing
    Tang, Shumin
    Li, Aimin
    Lin, Lin
    Wei, Yinting
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 2403 - 2411
  • [40] Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat
    Ke, HZ
    Qi, H
    Crawford, DT
    Chidsey-Frink, KL
    Simmons, HA
    Thompson, DD
    ENDOCRINOLOGY, 2000, 141 (04) : 1338 - 1344
12345